Jean Hubble

7.0k total citations
58 papers, 3.6k citations indexed

About

Jean Hubble is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Jean Hubble has authored 58 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 18 papers in Cellular and Molecular Neuroscience and 8 papers in Psychiatry and Mental health. Recurrent topics in Jean Hubble's work include Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (33 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Jean Hubble is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (33 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Jean Hubble collaborates with scholars based in United States, Switzerland and France. Jean Hubble's co-authors include William C. Koller, Karen Busenbark, Rajesh Pahwa, Robert A. Hauser, Kelly E. Lyons, C. Warren Olanow, Daniel D. Truong, Steven B. Wilkinson, Thorkild Norregaard and Alexander I. Tröster and has published in prestigious journals such as Neurology, Annals of Neurology and The Lancet Neurology.

In The Last Decade

Jean Hubble

58 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Hubble United States 31 2.9k 1.5k 318 317 288 58 3.6k
Manfred D. Muenter United States 26 2.9k 1.0× 1.3k 0.9× 350 1.1× 247 0.8× 327 1.1× 51 3.6k
Mark Lew United States 29 2.7k 0.9× 1.1k 0.7× 298 0.9× 348 1.1× 204 0.7× 86 3.5k
Carlos Singer United States 32 2.8k 1.0× 1.1k 0.7× 374 1.2× 409 1.3× 391 1.4× 134 3.8k
Tomoyoshi Kondo Japan 34 2.2k 0.8× 1.4k 0.9× 237 0.7× 167 0.5× 954 3.3× 132 3.7k
Daniel Truong United States 35 2.7k 0.9× 1.4k 0.9× 193 0.6× 292 0.9× 598 2.1× 136 3.9k
Renato P. Munhoz Canada 35 2.8k 1.0× 1.6k 1.1× 397 1.2× 457 1.4× 766 2.7× 225 4.2k
Marina Svetel Serbia 28 1.8k 0.6× 933 0.6× 239 0.8× 299 0.9× 491 1.7× 149 2.9k
Dirk Woitalla Germany 32 2.3k 0.8× 993 0.7× 332 1.0× 258 0.8× 944 3.3× 112 3.8k
Karla Eggert Germany 30 2.3k 0.8× 1.1k 0.7× 341 1.1× 311 1.0× 468 1.6× 77 3.4k
Cheryl Waters United States 39 3.7k 1.3× 1.3k 0.9× 540 1.7× 467 1.5× 649 2.3× 107 5.0k

Countries citing papers authored by Jean Hubble

Since Specialization
Citations

This map shows the geographic impact of Jean Hubble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Hubble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Hubble more than expected).

Fields of papers citing papers by Jean Hubble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Hubble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Hubble. The network helps show where Jean Hubble may publish in the future.

Co-authorship network of co-authors of Jean Hubble

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Hubble. A scholar is included among the top collaborators of Jean Hubble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Hubble. Jean Hubble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hubble, Jean, et al.. (2013). Dysport (Botulinum Toxin Type A) in Routine Therapeutic Usage. Clinical Neuropharmacology. 36(4). 122–127. 8 indexed citations
2.
Isaacson, Stuart, et al.. (2013). Apomorphine for Morning Akinesia Trial (Am Impakt). Journal of the Neurological Sciences. 333. e69–e70. 1 indexed citations
3.
Hauser, Robert A., et al.. (2012). AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. Journal of Neural Transmission. 120(2). 299–307. 19 indexed citations
4.
Hubble, Jean, et al.. (2012). Immunoresistance in Cervical Dystonia Patients After Treatment With AbobotulinumtoxinA. International Journal of Neuroscience. 122(7). 358–362. 13 indexed citations
5.
Olanow, C. Warren, Anthony H.V. Schapira, Peter A. LeWitt, et al.. (2006). TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet Neurology. 5(12). 1013–1020. 121 indexed citations
6.
Koller, William C., et al.. (2004). An open-label evaluation of the tolerability and safety of Stalevo� (carbidopa, levodopa and entacapone) in Parkinson?s disease patients experiencing wearing-off. Journal of Neural Transmission. 112(2). 221–230. 37 indexed citations
7.
Hauser, Robert A., et al.. (2003). Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD. Neurology. 61(3). 297–303. 237 indexed citations
8.
Hubble, Jean & Péter Novák. (2001). Pramipexole: a nonergot dopamine agonist as drug therapy in Parkinson’s disease. Expert Review of Neurotherapeutics. 1(1). 43–51. 12 indexed citations
9.
Hauser, Robert A., et al.. (2000). Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease. Movement Disorders. 15(3). 485–489. 49 indexed citations
10.
Hubble, Jean. (1999). NOVEL DRUGS FOR PARKINSON'S DISEASE. Medical Clinics of North America. 83(2). 525–536. 10 indexed citations
11.
Hubble, Jean, Karen Busenbark, Rajesh Pahwa, Kelly E. Lyons, & William C. Koller. (1997). Clinical expression of essential tremor: Effects of gender and age. Movement Disorders. 12(6). 969–972. 128 indexed citations
12.
Hubble, Jean, Karen Busenbark, Steven B. Wilkinson, et al.. (1997). Effects of thalamic deep brain stimulation based on tremor type and diagnosis. Movement Disorders. 12(3). 337–341. 49 indexed citations
13.
Miyawaki, Edison, Kelly Lyons, Rajesh Pahwa, et al.. (1997). Motor Complications of Chronic Levodopa Therapy in Parkinsonʼs Disease. Clinical Neuropharmacology. 20(6). 523–530. 62 indexed citations
14.
Hubble, Jean, Karen Busenbark, Steven B. Wilkinson, et al.. (1996). Deep brain stimulation for essential tremor. Neurology. 46(4). 1150–1153. 132 indexed citations
15.
Hubble, Jean, William C. Koller, N.R. Cutler, et al.. (1995). Pramipexole in Patients with Early Parkinsonʼs Disease. Clinical Neuropharmacology. 18(4). 338–347. 115 indexed citations
16.
Tröster, Alexander I., et al.. (1995). The influence of depression on cognition in Parkinson's disease. Neurology. 45(4). 672–676. 69 indexed citations
17.
Hurwitz, A, et al.. (1995). Erythrocyte thiolmethyltransferase. Neurology. 45(10). 1903–1906. 3 indexed citations
18.
Hubble, Jean, William C. Koller, & Cheryl Waters. (1993). Effects of Selegiline Dosing on Motor Fluctuations in Parkinsonʼs Disease. Clinical Neuropharmacology. 16(1). 83–87. 19 indexed citations
19.
Hubble, Jean, et al.. (1993). Interactive video conferencing: A means of providing interim care to parkinson's disease patients. Movement Disorders. 8(3). 380–382. 115 indexed citations
20.
Hubble, Jean, Karen Busenbark, & William C. Koller. (1989). Essential Tremor. Clinical Neuropharmacology. 12(6). 453–482. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manfred D. Muenter Breakdown of academic impact, for papers by Mark Lew Breakdown of academic impact, for papers by Carlos Singer Breakdown of academic impact, for papers by Tomoyoshi Kondo Breakdown of academic impact, for papers by Daniel Truong Breakdown of academic impact, for papers by Renato P. Munhoz Breakdown of academic impact, for papers by Marina Svetel Breakdown of academic impact, for papers by Dirk Woitalla Breakdown of academic impact, for papers by Karla Eggert Breakdown of academic impact, for papers by Cheryl Waters
Rankless by CCL
2026